软组织再生材料的开发平台报告:开发阶段，市场区隔，地区、国家，法规通行证，主要企业-2022年最新版

本报告提供全球软组织再生材料市场相关调查分析，重要的竞争情报、分析和洞察，以改进研发策略，识别具有强大产品组合的初创企业，制定有效的对抗策略以获得竞争优势，识别开发中的重要且多样的类型的软组织再生材料，市场进入与市场开拓的策略筹划，最有前途的开发平台的主要企业及有效的M&A计划，产品的目前开发阶段，领域，销售预定日详细的分析等相关资讯。

目录

第1章 目录

• 表格一览
• 图表一览

第2章 简介

• 软组织再生材料概要

第3章:开发中的产品

• 软组织再生材料:各开发阶段平台产品
• 软组织再生材料:各地区开发中产品
• 软组织再生材料:各法规通行证开发中产品
• 软组织再生材料:各核准预定日开发中产品
• 软组织再生材料:进行中的临床试验

第4章:软组织再生材料:企业开发中的开发中产品

• 软组织再生材料企业:各开发阶段平台产品
• 软组织再生材料:各开发阶段平台产品

第5章 软组织再生材料企业与产品概要

• Advanced Biotech Products Pvt Ltd 企业概要
• Colorado Therapeutics, LLC 企业概要
• credentis AG 企业概要
• Histocell SL 企业概要
• Indian Institute of Technology Bombay 企业概要
• Maxigen Biotech Inc 企业概要
• Medtronic Plc 企业概要
• Nobel Biocare Services AG 企业概要
• Novatissue SAS 企业概要
• Orthocell Ltd 企业概要
• Orthorebirth Co Ltd 企业概要
• Polytechnic University of Catalonia 企业概要
• Straumann Holding AG 企业概要
• SurgaColl Technologies Ltd 企业概要
• SweetBio, Inc. 企业概要
• Tetratherix Pty Ltd 企业概要
• Tigran Technologies AB 企业概要

第6章 软组织再生材料:最近的开发

第7章 附录

• 调查手法
• 关于GlobalData
• 咨询方式
• 免责声明

GlobalData's Medical Devices sector report, "Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Tissue Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue Regenerative Material is a biomaterial component which facilitates regeneration of lost periodontal hard and soft tissue.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Tissue Regenerative Materials under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Tissue Regenerative Materials and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Tissue Regenerative Materials under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Tissue Regenerative Materials Overview

3 Products under Development

• 3.1 Tissue Regenerative Materials - Pipeline Products by Stage of Development
• 3.2 Tissue Regenerative Materials - Pipeline Products by Territory
• 3.3 Tissue Regenerative Materials - Pipeline Products by Regulatory Path
• 3.4 Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
• 3.5 Tissue Regenerative Materials - Ongoing Clinical Trials

4 Tissue Regenerative Materials - Pipeline Products under Development by Companies

• 4.1 Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
• 4.2 Tissue Regenerative Materials - Pipeline Products by Stage of Development

5 Tissue Regenerative Materials Companies and Product Overview

• 5.1 Advanced Biotech Products Pvt Ltd Company Overview
• 5.2 Colorado Therapeutics, LLC Company Overview
• 5.3 credentis AG Company Overview
• 5.4 Histocell SL Company Overview
• 5.5 Indian Institute of Technology Bombay Company Overview
• 5.6 Maxigen Biotech Inc Company Overview
• 5.7 Medtronic Plc Company Overview
• 5.8 Nobel Biocare Services AG Company Overview
• 5.9 Novatissue SAS Company Overview
• 5.10 Orthocell Ltd Company Overview
• 5.11 Orthorebirth Co Ltd Company Overview
• 5.12 Polytechnic University of Catalonia Company Overview
• 5.13 Straumann Holding AG Company Overview
• 5.14 SurgaColl Technologies Ltd Company Overview
• 5.15 SweetBio, Inc. Company Overview
• 5.16 Tetratherix Pty Ltd Company Overview
• 5.17 Tigran Technologies AB Company Overview

6 Tissue Regenerative Materials- Recent Developments

• 6.1 May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
• 6.2 Apr 13, 2022: CollPlant To Present at the Aesthetics Innovation Summit 2022
• 6.3 Mar 24, 2022: CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
• 6.4 Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
• 6.5 Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
• 6.6 Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
• 6.7 Jan 07, 2022: Collagen Matrix Names Tony Orsini Chief Operating Officer
• 6.8 Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
• 6.9 Nov 18, 2021: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results
• 6.10 Oct 18, 2021: Straumann Group 2021 third-quarter financial results webcast invitation
• 6.11 Aug 19, 2021: CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
• 6.12 Jul 29, 2021: Invitation: Straumann Group 2021 half-year financial results webcast
• 6.13 Jul 15, 2021: Christian Ullrich joins Straumann Group's Executive Management Board as the new Group Chief Information Officer

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Tissue Regenerative Materials - Pipeline Products by Stage of Development
• Tissue Regenerative Materials - Pipeline Products by Territory
• Tissue Regenerative Materials - Pipeline Products by Regulatory Path
• Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
• Tissue Regenerative Materials - Ongoing Clinical Trials
• Tissue Regenerative Materials Companies - Pipeline Products by Stage of Development
• Tissue Regenerative Materials - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Tissue Regenerative Materials - Pipeline Products by Stage of Development
• Tissue Regenerative Materials - Pipeline Products by Territory
• Tissue Regenerative Materials - Pipeline Products by Regulatory Path
• Tissue Regenerative Materials - Pipeline Products by Estimated Approval Date
• Tissue Regenerative Materials - Ongoing Clinical Trials